S Protein and COVID-19: a Monocentric Prospective Study

计划入组 70 人 · 首次发布于 2022 年 4 月 28 日

A Phase I study to Evaluate the Tolerability, Safety, and Immunogenicity of a PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine in Healthy Adults

计划入组 90 人

CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)

计划入组 16 人 · 首次发布于 2020 年 11 月 13 日

Protein S human(Balfaxar, Beriplex, Kcentra, Octaplex)

Bivalent mRNA vaccine targeting S-protein (CureVac)

NL63 S protein AAV vector vaccine(Crucell)

Protein Sciences Corporation

United States

ALIFE HEALTH S A S

Colombia

HOUSE OF SUPPLEMENTS AUSTRALIA PTY LTD

Australia

Autoantibodies to Protein S Linked to Coagulopathy Following COVID-19 Vaccination

Blue Lake and CyanVac's Intranasal COVID-19 Vaccine Shows Promise in Phase 2a Trial

Nasal Spray Targeting Brain Enzyme zDHHC7 Shows Promise in Alzheimer's Treatment